HEALTH ITALIA S.P.A. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126 EUR | +1.61% |
|
+0.80% | +4.13% |
| Mar. 19 | Futures passive; BoJ abandons negative rates. | AN |
| Mar. 18 | Milan at parity; De Nora on bottom after accounts | AN |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 22.62 | 23.18 | - | - |
| Enterprise Value (EV) 1 | 31.93 | 25 | 23.18 | 23.18 |
| P/E ratio | 13.9 x | 5.9 x | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.63 x | 0.56 x | 0.51 x | 0.46 x |
| EV / Revenue | 0.9 x | 0.6 x | 0.51 x | 0.46 x |
| EV / EBITDA | 4.04 x | 3.22 x | 1.94 x | 1.77 x |
| EV / FCF | 15 x | 7.16 x | 16.8 x | 7.43 x |
| FCF Yield | 6.68% | 14% | 5.95% | 13.5% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 187 | 187 | - | - |
| Reference price 2 | 121.0 | 124.0 | 124.0 | 124.0 |
| Announcement Date | 3/9/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 35.67 | 41.58 | 45.74 | 50.31 |
| EBITDA 1 | - | 7.9 | 7.77 | 11.93 | 13.12 |
| EBIT 1 | - | 3.76 | 6.59 | 10.81 | 11.89 |
| Operating Margin | - | 10.54% | 15.85% | 23.63% | 23.63% |
| Earnings before Tax (EBT) 1 | 5.455 | 3.297 | 5.77 | - | - |
| Net income 1 | 3.697 | 1.646 | 4.04 | - | - |
| Net margin | - | 4.62% | 9.72% | - | - |
| EPS 2 | - | 8.700 | 21.00 | - | - |
| Free Cash Flow 1 | - | 2.134 | 3.49 | 1.38 | 3.12 |
| FCF margin | - | 5.98% | 8.39% | 3.02% | 6.2% |
| FCF Conversion (EBITDA) | - | 27.01% | 44.92% | 11.57% | 23.78% |
| FCF Conversion (Net income) | - | 129.6% | 86.39% | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/29/23 | 3/9/24 | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 9.3 | 1.82 | - | - |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.178 x | 0.2342 x | - | - |
| Free Cash Flow 1 | - | 2.13 | 3.49 | 1.38 | 3.12 |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 1.4 | 3.44 | 3.68 |
| Capex / Sales | - | - | 3.37% | 7.52% | 7.31% |
| Announcement Date | 3/29/23 | 3/9/24 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
124
EUR
Average target price
400
EUR
Spread / Average Target
+222.58%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.13% | 25.08M | |
| +5.34% | 1.32B |
- Stock Market
- Equities
- HI Stock
- Financials Health Italia S.p.A.